Neutralization-Sensitive R5-Tropic Simian-Human Immunodeficiency Virus SHIV-2873Nip, Which Carries env Isolated from an Infant with a Recent HIV Clade C Infection (vol 83, pg 1422, 2009)

• Type of Material: Article
• Authors: Nagadenahalli B. Siddappa, Harvard University; Ruijiang Song, Harvard University; Victor G. Kramer, Harvard University; Agnes-Laurence Chenine, Harvard University; Vijayakumar Velu, Harvard University; Helena Ong, Harvard University; Robert A. Rasmussen, Harvard University; Ricky D. Grisson, Harvard University; Charles Wood, Harvard University; Hong Zhang, Harvard University; Chipeppo Kankasa, Harvard University; Rama Rao Amara, Emory University; Jim Else, Emory University; Francis J. Novembre, Harvard University; David C. Montefiori, Harvard University; Ruth M. Ruprecht, Harvard University
• Language: English
• Date: 2009-08-15
• Publisher: American Society for Microbiology
• Publication Version: Final Published Version
• Copyright Statement: © 2009, American Society for Microbiology
• Final Published Version (URL): http://dx.doi.org/10.1128/JVI.01123-09
• Title of Journal or Parent Work: Journal of Virology
• ISSN: 0022-538X
• Volume: 83
• Issue: 16
• Start Page: 8297
• End Page: 8297
• Grant/Funding Information: This work was supported by National Institutes of Health grants R01 DE012937, R01 DE016013, and R37 AI034266 to R.M.R.; HD39620, TW01429, and RR15635 to C.W.; P01 AI048240 to R.M.R., C.W., R.A.R., and R.D.G.; contract AI30034 to D.C.M.; and base grant RR-000165 to the Yerkes National Primate Research Center.
• Keywords: Virology; Science & Technology; Life Sciences & Biomedicine
• Research Categories: Biology, Virology; Health Sciences, Immunology; Biology, Microbiology

Abstract

Human immunodeficiency virus clade C (HIV-C) accounts for >56% of all HIV infections worldwide. To investigate vaccine safety and efficacy in nonhuman primates, a pathogenic, R5-tropic, neutralization-sensitive simian-human immunodeficiency virus (SHIV) carrying HIV-C env would be desirable. We have constructed SHIV-2873Ni, an R5-tropic SHIV carrying a primary pediatric HIV-C env gene isolated from a 2-month-old Zambian infant, who died within 1 year of birth. SHIV-2873Ni was constructed using SHIV-1157ipd3N4 (R. J. Song, A. L. Chenine, R. A. Rasmussen, C. R. Ruprecht, S. Mirshahidi, R. D. Grisson, W. Xu, J. B. Whitney, L. M. Goins, H. Ong, P. L. Li, E. Shai-Kobiler, T. Wang, C. M. McCann, H. Zhang, C. Wood, C. Kankasa, W. E. Secor, H. M. McClure, E. Strobert, J. G. Else, and R. M. Ruprecht. J. Virol. 80:8729-8738, 2006) as the backbone, since the latter contains additional NF-κB sites in the long terminal repeats to enhance viral replicative capacity. The parental virus, SHIV-2873Ni, was serially passaged through five rhesus monkeys (RMs); SHIV-2873Nip, the resulting passaged virus, was reisolated from the fourth recipient about 1 year postinoculation. SHIV-2873Nip was replication competent in RM peripheral blood mononuclear cells of all random donors tested and was exclusively R5 tropic, and its env gene clustered with HIV-C by phylogenetic analysis; its high sensitivity to neutralization led to classification as a tier 1 virus. Indian-origin RMs were inoculated by different mucosal routes, resulting in high peak viral RNA loads. Signs of virus-induced disease include depletion of gut CD4+ T lymphocytes, loss of memory T cells in blood, and thrombocytopenia that resulted in fatal cerebral hemorrhage. SHIV-2873Nip is a highly replication-competent, mucosally transmissible, pathogenic R5-tropic virus that will be useful to study viral pathogenesis and to assess the efficacy of immunogens targeting HIV-C Env.